The changing landscape of molecular radiotherapy
Radionuclide therapy is probably the only field of medicine that allows direct imaging of a drug as it is used to treat cancer. Radioiodine was first used over 70 years ago for the treatment of benign thyroid disease and thyroid cancer. Levels of activity to administer were determined empirically, influenced largely by limitations in supply […]

Dr Glenn Flux
Royal Marsden Hospital NHS Foundation Trust